Imagine taking a common prescription for skin or gut inflammation. You expect relief, not a new set of problems. Now imagine that the same medicine causes different issues depending on whether you were born male or female.
This is exactly what a massive new analysis has uncovered.
The Hidden Split in Medicine
Doctors have long used a specific class of drugs called PDE4 inhibitors to treat conditions like psoriasis and Crohn's disease. The most famous ones are apremilast, crisaborole, and roflumilast.
For years, we treated everyone the same. We assumed if a drug worked for one person, it would work for another. But this study suggests that biology is more complex than that.
Millions of people take these medications every day. They help clear up red, itchy skin and calm down inflamed guts. But side effects can be scary. Dizziness, heart palpitations, and infections are common worries.
The frustrating part? We didn't know who was most at risk until now. If a woman feels dizzy after taking a pill, doctors might think it's just a side effect. But what if men are less likely to report it? Or what if certain risks only show up in one sex?
The Surprising Shift
We used to think these drugs were safe for everyone. That belief is still true in general. But the details are changing.
This study looked at millions of reports from the FDA database. It found clear patterns that split by gender. For example, women reported more dizziness and heart issues with one specific drug. Men reported different problems with the others.
What Scientists Didn't Expect
Think of your body like a house with different locks on the doors. These drugs try to open specific locks to stop inflammation. But sometimes, the key gets stuck differently depending on the house.
In biology, men and women have different hormone levels and genetic structures. This study suggests those differences change how the drugs work inside the body. It's like a traffic jam: the same road gets clogged differently depending on who is driving.
Researchers dug through the FDA's safety database from 2004 to 2025. They looked at over 137,000 reports involving these three drugs.
They cleaned the data carefully to avoid counting the same mistake twice. Then, they used special math tools to find signals that stood out. They separated the results by sex to see the real differences.
The results were distinct for each drug.
With apremilast, women reported dizziness, heart racing, and infections much more often. The time it took for these side effects to start was also longer, averaging about three weeks.
Crisaborole showed a different picture. Men reported issues related to how the product was used more often. These problems usually showed up very quickly, often within just a few days.
Roflumilast had male-skewed signals. Men reported more issues related to metabolism and even cancer risks. Again, the timing was slow, taking about six weeks on average to appear.
This doesn't mean this treatment is available yet.
The Catch
Here is the important part: this does not mean these drugs are unsafe. It means we need to watch them more closely.
Doctors need to know that a woman might need different monitoring than a man. If a patient feels dizzy, the doctor should ask about their sex and medical history. This helps them decide if the side effect is normal or a warning sign.
Experts say this fits into a bigger trend. Medicine is moving toward "precision health." This means treating people based on their unique biology, not just their disease name.
This study adds to the growing pile of evidence that sex matters in drug safety. It pushes the medical community to talk openly about these risks.
If you take these medications, talk to your doctor about your history. Mention any side effects you feel, no matter how small they seem.
These drugs are still widely used and helpful. But being aware of the differences helps you stay safe. You might need to switch to a different drug if one doesn't fit your body well.
This study relies on reports sent to the FDA. People often forget to report minor side effects. This means the real numbers might be even higher than we see. Also, the data comes from reports, not a controlled experiment.
What happens next? Doctors will likely start asking about sex history more often when prescribing these drugs.
We may see new guidelines that tell doctors to watch for specific side effects in specific groups. More research will follow to understand exactly why these differences happen.
Until then, the message is simple: know your body, know your risks, and talk to your doctor.
